Abstract
Chronic widespread pain (CWP) is defined as musculoskeletal pain in multiple locations that represents generalized body pain. Fibromyalgia syndrome (FMS) is a subset of CWP, characterized with CWP, hyperalgesia, and a host of other functional and mood disturbances, such as fatigue, poor sleep, cognitive problems, depression, and anxiety (Wolfe et al., 1990). Conventionally, CWP and FMS have been treated as overlapping yet somewhat separate illness entities, resulting in two lines of research literature. In this chapter, we will provide a critical review on the disability issues of people with CWP, which include people with FMS. We will include information from research investigating FMS, CWP, or both. Thus, it will be helpful to first present how each condition is conceptualized and assessed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abusdal, U. G., Hagen, K. B., & Bjorndal, A. (1997). Self-reported chronic muscle pain among women in Oslo. Tidsskrift for den Norske Lægeforening, 117(11), 1606–1610.
Adler, G. K., Kinsley, B. T., Hurwitz, S., Mossey, C. J., & Goldenberg, D. L. (1999). Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. American Journal of Medicine, 106(5), 534–543.
Al-Allaf, A. W. (2007). Work disability and health system utilization in patients with fibromyalgia syndrome. Journal of Clinical Rheumatology, 13(4), 199–201.
Al-Obaidi, S. M., Nelson, R. M., Al-Awadhi, S., & Al-Shuwaie, N. (2000). The role of anticipation and fear of pain in the persistence of avoidance behavior in patients with chronic low back pain. Spine (Phila Pa 1976), 25(9), 1126–1131.
Amris, K., Waehrens, E. E., Jespersen, A., Bliddal, H., & Danneskiold-Samsoe, B. (2011). Observation-based assessment of functional ability in patients with chronic widespread pain: A cross-sectional study. Pain, 152(11), 2470–2476.
Arnold, L. M., Keck, P. E., Jr., & Welge, J. A. (2000). Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics, 41(2), 104–113.
Arnold, L. M., Russell, I. J., Diri, E. W., Duan, W. R., Young, J. P., Jr., Sharma, U., et al. (2008). A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. The Journal of Pain, 9(9), 792–805.
Arroyo, J. F., & Cohen, M. L. (1993). Abnormal responses to electrocutaneous stimulation in fibromyalgia [see comments]. Journal of Rheumatology, 20(11), 1925–1931.
Assefi, N. P., Coy, T. V., Uslan, D., Smith, W. R., & Buchwald, D. (2003). Financial, occupational, and personal consequences of disability in patients with chronic fatigue syndrome and fibromyalgia compared to other fatiguing conditions. Journal of Rheumatology, 30(4), 804–808.
Bengtsson, A., & Henriksson, K. G. (1989). The muscle in fibromyalgia–A review of Swedish studies. Journal of Rheumatology. Supplement, 19, 144–149.
Bennett, R. M., Cook, D. M., Clark, S. R., Burckhardt, C. S., & Campbell, S. M. (1997). Hypothalamic-pituitary-insulin-like growth factor-I axis dysfunction in patients with fibromyalgia. Journal of Rheumatology, 24(7), 1384–1389.
Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007). An internet survey of 2,596 people with fibromyalgia. BMC Musculoskeletal Disorders, 8, 27.
Berger, A., Dukes, E., Martin, S., Edelsberg, J., & Oster, G. (2007). Characteristics and healthcare costs of patients with fibromyalgia syndrome. International Journal of Clinical Practice, 61(9), 1498–1508.
Bergman, S., Herrstrom, P., Hogstrom, K., Petersson, I. F., Svensson, B., & Jacobsson, L. T. (2001). Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study. Journal of Rheumatology, 28(6), 1369–1377.
Bombardier, C. H., & Buchwald, D. (1996). Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use. Medical Care, 34(9), 924–930.
Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The fibromyalgia impact questionnaire: Development and validation. Journal of Rheumatology, 18(5), 728–733.
Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1993). Fibromyalgia and quality of life: A comparative analysis. Journal of Rheumatology, 20(3), 475–479.
Buskila, D., Abramov, G., Biton, A., & Neumann, L. (2000). The prevalence of pain complaints in a general population in Israel and its implications for utilization of health services. Journal of Rheumatology, 27(6), 1521–1525.
Buskila, D., Neumann, L., Odes, L. R., Schleifer, E., Depsames, R., & Abu-Shakra, M. (2001). The prevalence of musculoskeletal pain and fibromyalgia in patients hospitalized on internal medicine wards. Seminars in Arthritis and Rheumatism, 30(6), 411–417.
Cardol, M., de Jong, B. A., van den Bos, G. A., Beelem, A., de Groot, I. J., & de Haan, R. J. (2002). Beyond disability: Perceived participation in people with a chronic disabling condition. Clinical Rehabilitation, 16(1), 27–35.
Chandran, A., Schaefer, C., Ryan, K., Baik, R., McNett, M., & Zlateva, G. (2012). The comparative economic burden of mild, moderate, and severe fibromyalgia: Results from a retrospective chart review and cross-sectional survey of working-age U.S. adults. Journal of Managed Care Pharmacy, 18(6), 415–426.
Clauw, D. J. (2008). Pharmacotherapy for patients with fibromyalgia. Journal of Clinical Psychiatry, 69(Suppl 2), 25–29.
Clauw, D. J., Arnold, L. M., & McCarberg, B. H. (2011). The science of fibromyalgia. Mayo Clinic Proceedings, 86(9), 907–911.
Clauw, D. J., & Crofford, L. J. (2003). Chronic widespread pain and fibromyalgia: What we know, and what we need to know. Best Practice & Research. Clinical Rheumatology, 17(4), 685–701.
Cohen, H., Neumann, L., Shore, M., Amir, M., Cassuto, Y., & Buskila, D. (2000). Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability. Seminars in Arthritis and Rheumatism, 29(4), 217–227.
Crofford, L. J., Pillemer, S. R., Kalogeras, K. T., Cash, J. M., Michelson, D., Kling, M. A., et al. (1994). Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis and Rheumatism, 37(11), 1583–1592.
Croft, P., Rigby, A. S., Boswell, R., Schollum, J., & Silman, A. (1993). The prevalence of chronic widespread pain in the general population. Journal of Rheumatology, 20(4), 710–713.
de Gier, M., Peters, M. L., & Vlaeyen, J. W. (2003). Fear of pain, physical performance, and attentional processes in patients with fibromyalgia. Pain, 104(1–2), 121–130.
De Girolama, G. (1991). Epidemiology and social costs of low back pain and fibromyalgia. Clinical Journal of Pain, 7(Suppl 1), S1–S7.
Di Franco, M., Iannuccelli, C., & Valesini, G. (2010). Neuroendocrine immunology of fibromyalgia. Annals of the New York Academy of Sciences, 1193, 84–90.
Dobkin, P. L., De Civita, M., Abrahamowicz, M., Bernatsky, S., Schulz, J., Sewitch, M., et al. (2003). Patient-physician discordance in fibromyalgia. Journal of Rheumatology, 30(6), 1326–1334.
Drewes, A. M., Andreasen, A., Schroder, H. D., Hogsaa, B., & Jennum, P. (1993). Pathology of skeletal muscle in fibromyalgia: A histo-immuno-chemical and ultrastructural study. British Journal of Rheumatology, 32(6), 479–483.
Durette, M. R., Rodriquez, A. A., Agre, J. C., & Silverman, J. L. (1991). Needle electromyographic evaluation of patients with myofascial or fibromyalgic pain. American Journal of Physical Medicine and Rehabilitation, 70(3), 154–156.
Ejlertsson, G., Eden, L., & Leden, I. (2002). Predictors of positive health in disability pensioners: A population-based questionnaire study using Positive Odds Ratio. BMC Public Health, 2, 20.
Elam, M., Johansson, G., & Wallin, B. G. (1992). Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain, 48(3), 371–375.
Ernberg, M., Voog, U., Alstergren, P., Lundeberg, T., & Kopp, S. (2000). Plasma and serum serotonin levels and their relationship to orofacial pain and anxiety in fibromyalgia. Journal of Orofacial Pain, 14(1), 37–46.
Forman-Hoffman, V. L., Peloso, P. M., Black, D. W., Woolson, R. F., Letuchy, E. M., & Doebbeling, B. N. (2007). Chronic widespread pain in veterans of the first Gulf War: Impact of deployment status and associated health effects. The Journal of Pain, 8(12), 954–961.
Forseth, K. O., & Gran, J. T. (1992). The prevalence of fibromyalgia among women aged 20–49 years in Arendal, Norway. Scandinavian Journal of Rheumatology, 21(2), 74–78.
Gadalla, T. (2008). Association of comorbid mood disorders and chronic illness with disability and quality of life in Ontario, Canada. Chronic Diseases in Canada, 28(4), 148–154.
Geisser, M. E., Palmer, R. H., Gendreau, R. M., Wang, Y., & Clauw, D. J. (2010). A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia. Pain Practice, 11(2), 120–131.
Gerdle, B., Bjork, J., Coster, L., Henriksson, K., Henriksson, C., & Bengtsson, A. (2008). Prevalence of widespread pain and associations with work status: A population study. BMC Musculoskeletal Disorders, 9, 102.
Gibson, S. J., Littlejohn, G. O., Gorman, M. M., Helme, R. D., & Granges, G. (1994). Altered heat pain thresholds and cerebral event-related potentials following painful CO2 laser stimulation in subjects with fibromyalgia syndrome. Pain, 58(2), 185–193.
Goldenberg, D. L. (1999). Fibromyalgia syndrome a decade later: What have we learned? Archives of Internal Medicine, 159(8), 777–785.
Gowers, W. (1904). Lumbago: Its lessons and analogues. British Medical Journal, 1, 117–121.
Gracely, R. H., Petzke, F., Wolf, J. M., & Clauw, D. J. (2002). Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis and Rheumatism, 46(5), 1333–1343.
Hamaty, D., Valentine, J. L., Howard, R., Howard, C. W., Wakefield, V., & Patten, M. S. (1989). The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: A 5-month study. Journal of Rheumatology. Supplement, 19, 164–168.
Hardt, J., Jacobsen, C., Goldberg, J., Nickel, R., & Buchwald, D. (2008). Prevalence of chronic pain in a representative sample in the United States. Pain Medicine, 9(7), 803–812.
Hassett, A. L., & Williams, D. A. (2011). Non-pharmacological treatment of chronic widespread musculoskeletal pain. Best Practice & Research. Clinical Rheumatology, 25(2), 299–309.
Hawley, D. J., Wolfe, F., & Cathey, M. A. (1988). Pain, functional disability, and psychological status: A 12-month study of severity in fibromyalgia. Journal of Rheumatology, 15(10), 1551–1556.
Heikkila, S., Ronni, S., Kautiainen, H. J., & Kauppi, M. J. (2002). Functional impairment in spondyloarthropathy and fibromyalgia. Journal of Rheumatology, 29(7), 1415–1419.
Helmer, D. A., Chandler, H. K., Quigley, K. S., Blatt, M., Teichman, R., & Lange, G. (2009). Chronic widespread pain, mental health, and physical role function in OEF/OIF veterans. Pain Medicine, 10(7), 1174–1182.
Henriksson, C., & Liedberg, G. (2000). Factors of importance for work disability in women with fibromyalgia. Journal of Rheumatology, 27(5), 1271–1276.
Hidding, A., van Santen, M., De Klerk, E., Gielen, X., Boers, M., Geenen, R., et al. (1994). Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. Journal of Rheumatology, 21(5), 818–823.
Howard, K. J., Mayer, T. G., Neblett, R., Perez, Y., Cohen, H., & Gatchel, R. J. (2010). Fibromyalgia syndrome in chronic disabling occupational musculoskeletal disorders: Prevalence, risk factors, and posttreatment outcomes. Journal of Occupational and Environmental Medicine, 52(12), 1186–1191.
Hunt, I. M., Silman, A. J., Benjamin, S., McBeth, J., & Macfarlane, G. J. (1999). The prevalence and associated features of chronic widespread pain in the community using the ‘Manchester’ definition of chronic widespread pain. Rheumatology (Oxford), 38(3), 275–279.
Jacobsen, S., & Holm, B. (1992). Muscle strength and endurance compared to aerobic capacity in primary fibromyalgia syndrome. Clinical and Experimental Rheumatology, 10(4), 419–420.
Julien, N., Goffaux, P., Arsenault, P., & Marchand, S. (2005). Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain, 114(1–2), 295–302.
Kadetoff, D., & Kosek, E. (2010). Evidence of reduced sympatho-adrenal and hypothalamic-pituitary activity during static muscular work in patients with fibromyalgia. Journal of Rehabilitation Medicine, 42(8), 765–772.
Kato, K., Sullivan, P. F., Evengard, B., & Pedersen, N. L. (2006). Chronic widespread pain and its comorbidities: A population-based study. Archives of Internal Medicine, 166(15), 1649–1654.
Katz, R. S., Wolfe, F., & Michaud, K. (2006). Fibromyalgia diagnosis: A comparison of clinical, survey, and American College of Rheumatology criteria. Arthritis and Rheumatism, 54(1), 169–176.
Kleinman, N., Harnett, J., Melkonian, A., Lynch, W., Kaplan-Machlis, B., & Silverman, S. L. (2009). Burden of fibromyalgia and comparisons with osteoarthritis in the workforce. Journal of Occupational and Environmental Medicine, 51(12), 1384–1393.
Kosek, E., & Hansson, P. (1997). Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain, 70(1), 41–51.
Kraft, G. H., Johnson, E. W., & LaBan, M. M. (1968). The fibrositis syndrome. Archives of Physical Medicine and Rehabilitation, 49(3), 155–162.
Kurtze, N., Gundersen, K. T., & Svebak, S. (1999). Quality of life, functional disability and lifestyle among subgroups of fibromyalgia patients: The significance of anxiety and depression. British Journal of Medical Psychology, 72(Pt 4), 471–484.
Lautenbacher, S., Rollman, G. B., & McCain, G. A. (1994). Multi-method assessment of experimental and clinical pain in patients with fibromyalgia. Pain, 59(1), 45–53.
Lawrence, R. C., Felson, D. T., Helmick, C. G., Arnold, L. M., Choi, H., Deyo, R. A., et al. (2008). Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis and Rheumatism, 58(1), 26–35.
Lemstra, M., & Olszynski, W. P. (2005). The effectiveness of multidisciplinary rehabilitation in the treatment of fibromyalgia: a randomized controlled trial. Clinical Journal of Pain, 21(2), 166–174.
Lerma, C., Martinez, A., Ruiz, N., Vargas, A., Infante, O., & Martinez-Lavin, M. (2011). Nocturnal heart rate variability parameters as potential fibromyalgia biomarker: Correlation with symptoms severity. Arthritis Research and Therapy, 13(6), R185.
Liedberg, G. M., & Henriksson, C. M. (2002). Factors of importance for work disability in women with fibromyalgia: An interview study. Arthritis and Rheumatism, 47(3), 266–274.
Light, A. R., Bateman, L., Jo, D., Hughen, R. W., Vanhaitsma, T. A., White, A. T., et al. (2012). Gene expression alterations at baseline and following moderate exercise in patients with chronic fatigue syndrome and fibromyalgia syndrome. Journal of Internal Medicine, 271(1), 64–81.
Light, A. R., White, A. T., Hughen, R. W., & Light, K. C. (2009). Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. The Journal of Pain, 10(10), 1099–1112.
Lindell, L., Bergman, S., Petersson, I. F., Jacobsson, L. T., & Herrstrom, P. (2000). Prevalence of fibromyalgia and chronic widespread pain. Scandinavian Journal of Primary Health Care, 18(3), 149–153.
Loevinger, B. L., Muller, D., Alonso, C., & Coe, C. L. (2007). Metabolic syndrome in women with chronic pain. Metabolism, 56(1), 87–93.
Lundberg, G., & Gerdle, B. (2002). Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of fibromyalgia syndrome. Journal of Rheumatology, 29(3), 603–613.
MacFarlane, G. J., Croft, P. R., Schollum, J., & Silman, A. J. (1996). Widespread pain: Is an improved classification possible? Journal of Rheumatology, 23(9), 1628–1632.
Malt, E. A., Olafsson, S., Aakvaag, A., Lund, A., & Ursin, H. (2003). Altered dopamine D2 receptor function in fibromyalgia patients: A neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. Journal of Affective Disorders, 75(1), 77–82.
Mannerkorpi, K., Burckhardt, C. S., & Bjelle, A. (1994). Physical performance characteristics of women with fibromyalgia. Arthritis Care and Research, 7(3), 123–129.
Mannerkorpi, K., & Gard, G. (2012). Hinders for continued work among persons with fibromyalgia. BMC Musculoskeletal Disorders, 13, 96.
Martinez, J. E., Ferraz, M. B., Sato, E. I., & Atra, E. (1995). Fibromyalgia versus rheumatoid arthritis: A longitudinal comparison of the quality of life. Journal of Rheumatology, 22(2), 270–274.
Martinez-Lavin, M. (2007). Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia. Arthritis Research and Therapy, 9(4), 216.
Mayer, T. G., Towns, B. L., Neblett, R., Theodore, B. R., & Gatchel, R. J. (2008). Chronic widespread pain in patients with occupational spinal disorders: Prevalence, psychiatric comorbidity, and association with outcomes. Spine (Phila Pa 1976), 33(17), 1889–1897.
McBeth, J., Nicholl, B. I., Cordingley, L., Davies, K. A., & Macfarlane, G. J. (2010). Chronic widespread pain predicts physical inactivity: Results from the prospective EPIFUND study. European Journal of Pain, 14(9), 972–979.
McCain, G. A., Cameron, R., & Kennedy, J. C. (1989). The problem of long-term disability payments and litigation in primary fibromyalgia: The Canadian perspective. Journal of Rheumatology. Supplement, 19, 174–176.
McCarberg, B., Barkin, R. L., Wright, J. A., Cronan, T. A., Groessl, E., & Schmidt, S. M. (2003). Tender points as predictors of distress and the pharmacologic management of fibromyalgia syndrome. American Journal of Therapy, 10(3), 176–192.
Middleton, G. D., McFarlin, J. E., & Lipsky, P. E. (1994). The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus [see comments]. Arthritis and Rheumatism, 37(8), 1181–1188.
Natvig, B., Bruusgaard, D., & Eriksen, W. (2001). Localized low back pain and low back pain as part of widespread musculoskeletal pain: Two different disorders? A cross-sectional population study. Journal of Rehabilitation Medicine, 33(1), 21–25.
Nielens, H., Boisset, V., & Masquelier, E. (2000). Fitness and perceived exertion in patients with fibromyalgia syndrome. Clinical Journal of Pain, 16(3), 209–213.
Noller, V., & Sprott, H. (2003). Prospective epidemiological observations on the course of the disease in fibromyalgia patients. Journal of Negative Results in Biomedicine, 2, 4.
Nordeman, L., Gunnarsson, R., & Mannerkorpi, K. (2012). Prevalence and characteristics of widespread pain in female primary health care patients with chronic low back pain. Clinical Journal of Pain, 28(1), 65–72.
Normand, E., Potvin, S., Gaumond, I., Cloutier, G., Corbin, J. F., & Marchand, S. (2011). Pain inhibition is deficient in chronic widespread pain but normal in major depressive disorder. Journal of Clinical Psychiatry, 72(2), 219–224.
Norregaard, J., Bulow, P. M., Mehlsen, J., & Danneskiold-Samsoe, B. (1994). Biochemical changes in relation to a maximal exercise test in patients with fibromyalgia. Clinical Physiology, 14(2), 159–167.
Okifuji, A., Donaldson, G. W., Barck, L., & Fine, P. G. (2010). Relationship between fibromyalgia and obesity in pain, function, mood, and sleep. The Journal of Pain, 11(12), 1329–1337.
Okifuji, A., & Turk, D. C. (2002). Stress and psychophysiological dysregulation in patients with fibromyalgia syndrome. Applied Psychophysiology and Biofeedback, 27(2), 129–141.
Pamuk, O. N., Yesil, Y., & Cakir, N. (2006). Factors that affect the number of tender points in fibromyalgia and chronic widespread pain patients who did not meet the ACR 1990 criteria for fibromyalgia: Are tender points a reflection of neuropathic pain? Seminars in Arthritis and Rheumatism, 36(2), 130–134.
Papageorgiou, A. C., Silman, A. J., & Macfarlane, G. J. (2002). Chronic widespread pain in the population: A seven year follow up study. Annals of the Rheumatic Diseases, 61(12), 1071–1074.
Park, J. H., Phothimat, P., Oates, C. T., Hernanz-Schulman, M., & Olsen, N. J. (1998). Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia. Arthritis and Rheumatism, 41(3), 406–413.
Penrod, J. R., Bernatsky, S., Adam, V., Baron, M., Dayan, N., & Dobkin, P. L. (2004). Health services costs and their determinants in women with fibromyalgia. Journal of Rheumatology, 31(7), 1391–1398.
Petzke, F., Clauw, D. J., Ambrose, K., Khine, A., & Gracely, R. H. (2003). Increased pain sensitivity in fibromyalgia: Effects of stimulus type and mode of presentation. Pain, 105(3), 403–413.
Prescott, E., Kjoller, M., Jacobsen, S., Bulow, P. M., Danneskiold-Samsoe, B., & Kamper-Jorgensen, F. (1993). Fibromyalgia in the adult Danish population: I. A prevalence study. Scandinavian Journal of Rheumatology, 22(5), 233–237.
Raspe, H., & Croft, P. (1995). Fibromyalgia. Baillieres Clinical Rheumatology, 9(3), 599–614.
Richardson, J. C., Ong, B. N., & Sim, J. (2008). Experiencing and controlling time in everyday life with chronic widespread pain: A qualitative study. BMC Musculoskeletal Disorders, 9, 3.
Rivera, J., Esteve-Vives, J., Vallejo, M. A., & Rejas, J. (2011). Factors associated with temporary work disability in patients with fibromyalgia. Rheumatology International, 31(11), 1471–1477.
Robinson, R. L., Birnbaum, H. G., Morley, M. A., Sisitsky, T., Greenberg, P. E., & Claxton, A. J. (2003). Economic cost and epidemiological characteristics of patients with fibromyalgia claims. Journal of Rheumatology, 30(6), 1318–1325.
Russell, I. J., Michalek, J. E., Vipraio, G. A., Fletcher, E. M., Javors, M. A., & Bowden, C. A. (1992). Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome [see comments]. Journal of Rheumatology, 19(1), 104–109.
Russell, I. J., Vaeroy, H., Javors, M., & Nyberg, F. (1992). Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis and Rheumatism, 35(5), 550–556.
Sallinen, M., Kukkurainen, M. L., Peltokallio, L., & Mikkelsson, M. (2010). Women’s narratives on experiences of work ability and functioning in fibromyalgia. Musculoskeletal Care, 8(1), 18–26.
Sarzi-Puttini, P., Buskila, D., Carrabba, M., Doria, A., & Atzeni, F. (2008). Treatment strategy in fibromyalgia syndrome: Where are we now? Seminars in Arthritis and Rheumatism, 37(6), 353–365.
Sherman, J. J., Turk, D. C., & Okifuji, A. (2000). Prevalence and impact of posttraumatic stress disorder-like symptoms on patients with fibromyalgia syndrome. Clinical Journal of Pain, 16(2), 127–134.
Silverman, S., Dukes, E. M., Johnston, S. S., Brandenburg, N. A., Sadosky, A., & Huse, D. M. (2009). The economic burden of fibromyalgia: Comparative analysis with rheumatoid arthritis. Current Medical Research and Opinion, 25(4), 829–840.
Simons, D. G. (1975). Muscle pain syndromes–Part I. American Journal of Physical Medicine, 54(6), 289–311.
Skouen, J. S., Grasdal, A., & Haldorsen, E. M. (2006). Return to work after comparing outpatient multidisciplinary treatment programs versus treatment in general practice for patients with chronic widespread pain. European Journal of Pain, 10(2), 145–152.
Smythe, H. (1972). Nonarticular rheumatism and the fibrositis syndrome. In L. Hollander (Ed.), Arthritis and allied conditions; a textbook of rheumatology (8th ed., pp. 874–884). Philadelphia, PA: Lea & Febiger.
Social Security Administration. (2012). Social security ruling, RSR 12–2: Title II and XVI: Evaluation of fibromyalgia. In F. Register (Ed.) (Vol. 77, pp. 43640–43644).
Sprott, H., Rzanny, R., Reichenbach, J. R., Kaiser, W. A., Hein, G., & Stein, G. (2000). 31P magnetic resonance spectroscopy in fibromyalgic muscle. Rheumatology (Oxford), 39(10), 1121–1125.
Staud, R. (2011). Peripheral pain mechanisms in chronic widespread pain. Best Practice & Research. Clinical Rheumatology, 25(2), 155–164.
Staud, R., Price, D. D., Robinson, M. E., Mauderli, A. P., & Vierck, C. J. (2004). Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls. Pain, 110(3), 689–696.
Stockman, R. (1904). The causes, pathology, and treatment of chronic rheumatism. Edinburgh Medical Journal, 15, 107–116.
Straube, S., Moore, R. A., Paine, J., Derry, S., Phillips, C. J., Hallier, E., et al. (2011). Interference with work in fibromyalgia: Effect of treatment with pregabalin and relation to pain response. BMC Musculoskeletal Disorders, 12, 125.
Toda, K. (2007). The prevalence of fibromyalgia in Japanese workers. Scandinavian Journal of Rheumatology, 36(2), 140–144.
Turk, D. C., Okifuji, A., Starz, T. W., & Sinclair, J. D. (1996). Effects of type of symptom onset on psychological distress and disability in fibromyalgia syndrome patients. Pain, 68(2–3), 423–430.
Turk, D. C., Robinson, J. P., & Burwinkle, T. (2004). Prevalence of fear of pain and activity in patients with fibromyalgia syndrome. The Journal of Pain, 5(9), 483–490.
van Denderen, J. C., Boersma, J. W., Zeinstra, P., Hollander, A. P., & van Neerbos, B. R. (1992). Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): Is PFS a disorder of neuroendocrine reactivity? Scandinavian Journal of Rheumatology, 21(1), 35–37.
Vlaeyen, J. W., Kole-Snijders, A. M., Boeren, R. G., & van Eek, H. (1995). Fear of movement/(re)injury in chronic low back pain and its relation to behavioral performance. Pain, 62(3), 363–372.
Waehrens, E. E., Amris, K., & Fisher, A. G. (2010). Performance-based assessment of activities of daily living (ADL) ability among women with chronic widespread pain. Pain, 150(3), 535–541.
White, L. A., Birnbaum, H. G., Kaltenboeck, A., Tang, J., Mallett, D., & Robinson, R. L. (2008). Employees with fibromyalgia: Medical comorbidity, healthcare costs, and work loss. Journal of Occupational and Environmental Medicine, 50(1), 13–24.
White, K. P., Nielson, W. R., Harth, M., Ostbye, T., & Speechley, M. (2002). Does the label “fibromyalgia” alter health status, function, and health service utilization? A prospective, within-group comparison in a community cohort of adults with chronic widespread pain. Arthritis and Rheumatism, 47(3), 260–265.
White, K. P., Speechley, M., Harth, M., & Ostbye, T. (1999). Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: The London Fibromyalgia Epidemiology Study. Arthritis and Rheumatism, 42(1), 76–83.
Winkelmann, A., Perrot, S., Schaefer, C., Ryan, K., Chandran, A., Sadosky, A., et al. (2011). Impact of fibromyalgia severity on health economic costs: Results from a European cross-sectional study. Applied Health Economics and Health Policy, 9(2), 125–136.
Wolfe, F. (1997). The relation between tender points and fibromyalgia symptom variables: Evidence that fibromyalgia is not a discrete disorder in the clinic. Annals of the Rheumatic Diseases, 56(4), 268–271.
Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., et al. (1997a). Health status and disease severity in fibromyalgia: Results of a six-center longitudinal study. Arthritis and Rheumatism, 40(9), 1571–1579.
Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., et al. (1997b). Work and disability status of persons with fibromyalgia. Journal of Rheumatology, 24(6), 1171–1178.
Wolfe, F., Clauw, D. J., Fitzcharles, M. A., Goldenberg, D. L., Katz, R. S., Mease, P., et al. (2010). The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care & Research, 62(5), 600–610.
Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995). The prevalence and characteristics of fibromyalgia in the general population. Arthritis and Rheumatism, 38(1), 19–28.
Wolfe, F., Russell, I. J., Vipraio, G., Ross, K., & Anderson, J. (1997). Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. Journal of Rheumatology, 24(3), 555–559.
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., et al. (1990). The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee [see comments]. Arthritis and Rheumatism, 33(2), 160–172.
Wood, P. B., Patterson, J. C., II, Sunderland, J. J., Tainter, K. H., Glabus, M. F., & Lilien, D. L. (2007). Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: A pilot study. The Journal of Pain, 8(1), 51–58.
Xiao, Y., He, W., & Russell, I. J. (2011). Genetic polymorphisms of the beta2-adrenergic receptor relate to guanosine protein-coupled stimulator receptor dysfunction in fibromyalgia syndrome. Journal of Rheumatology, 38(6), 1095–1103.
Yunus, M. B., Arslan, S., & Aldag, J. C. (2002). Relationship between body mass index and fibromyalgia features. Scandinavian Journal of Rheumatology, 31(1), 27–31.
Yunus, M. B., Masi, A. T., & Aldag, J. C. (1989). Preliminary criteria for primary fibromyalgia syndrome (PFS): Multivariate analysis of a consecutive series of PFS, other pain patients, and normal subjects. Clinical and Experimental Rheumatology, 7(1), 63–69.
Yunus, M., Masi, A. T., Calabro, J. J., Miller, K. A., & Feigenbaum, S. L. (1981). Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls. Seminars in Arthritis and Rheumatism, 11(1), 151–171.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Okifuji, A., Hare, B.D. (2014). Chronic Widespread Pain and Fibromyalgia Syndrome. In: Gatchel, R., Schultz, I. (eds) Handbook of Musculoskeletal Pain and Disability Disorders in the Workplace. Handbooks in Health, Work, and Disability. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0612-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0612-3_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0611-6
Online ISBN: 978-1-4939-0612-3
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)